SKK
SCMP

Shepherd Kaplan Krochuk’s Sucampo Pharmaceuticals, Inc. SCMP Stock Holding History

Shepherd Kaplan Krochuk’s Portfolio SCMP Stock Details SCMP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-11,998
Closed -$238K – 465
2015
Q3 		$238K Sell
11,998
-1,227
-9% -$28.1K 0.06% 224
2015
Q2 		$217K Buy
+13,225
New +$229K 0.04% 286
2014
Q1 		– Sell
-31,878
Closed -$300K – 674
2013
Q4 		$300K Buy
+31,878
New +$227K 0.04% 314

Other funds holding SCMP

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Prudential Financial
Prudential Financial Newark, New Jersey $81.2B AUM 27.81% 1-Year Est. Return
GAM
Gotham Asset Management New York $32.7B AUM 27.65% 1-Year Est. Return
KAM
Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return

Shepherd Kaplan Krochuk's SCMP Position: Q4 2015 in Review

Shepherd Kaplan Krochuk sold out of Sucampo Pharmaceuticals, Inc. (SCMP) in Q4 2015, closing a stake of 11,998 shares — an estimated $238K sold.

Shepherd Kaplan Krochuk first reported a position in SCMP in Q4 2013 and held it in 3 quarters. The position peaked at $300K in Q4 2013. 149 funds tracked by Wall St. Rank hold SCMP as of Q4 2015.

  • Shepherd Kaplan Krochuk reported no remaining Sucampo Pharmaceuticals, Inc. position as of Q4 2015 after selling out during the quarter.
  • Shepherd Kaplan Krochuk sold 11,998 Sucampo Pharmaceuticals, Inc. shares in Q4 2015, an estimated $238K.
  • Shepherd Kaplan Krochuk first reported a position in Sucampo Pharmaceuticals, Inc. in Q4 2013 and held it in 3 quarters.
  • Shepherd Kaplan Krochuk's Sucampo Pharmaceuticals, Inc. position peaked at $300K in Q4 2013.
  • 149 funds tracked by Wall St. Rank held Sucampo Pharmaceuticals, Inc. as of Q4 2015.

Based on Shepherd Kaplan Krochuk's 13F filing for Q4 2015, filed 16 Feb 2016.